Atlantic Bridge University Fund
VC Fund
Dublin, Ireland
Atlantic Bridge University Fund is a VC fund in Dublin focused on Health Care and Medical Device. Atlantic Bridge University Fund invest in entrepreneurs with the ambition to create world-class companies of scale. A €60m investment fund to accelerate the commercialisation of ground-breaking research and the scaling of global businesses.
- Total investments:
- 33
- Last investment:
- Lead investor:
- 55%
Last updated:
For AI agents: llms.txt
Industries Atlantic Bridge University Fund invests in
Stages Atlantic Bridge University Fund invests in
Countries Atlantic Bridge University Fund invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $823k–$3.9M
- Series A
- $3.1M–$34M
- Series B
- $16M–$80M
Investment Focus
Industry
- Health Care 5 (15%)
- Medical Device 5 (15%)
- Big Data 3 (9%)
- Software 2 (6%)
- Biotechnology 2 (6%)
Stage
- Seed 15 (45%)
- Series A 7 (21%)
- Series B 2 (6%)
- Funding Round 1 (3%)
- Venture - Series Unknown 1 (3%)
Country
- Ireland 17 (52%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Brian Long
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 19 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ProVerum Medical
|
ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. | $80M / Series B / Aug 25, 2025 | |
CroíValve
|
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation | $16M / Series B / Aug 07, 2024 | |
PlasmaBound
|
PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, byenabling reliable adhesive joining which is stronger than the composite structures themselves. | $2.5M / Venture - Series Unknown / May 01, 2022 | |
|
CroíValve
|
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation | $9.2M / Series A / Feb 04, 2022 | |
|
ProVerum Medical
|
ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. | Series A / Jan 11, 2022 | |
|
ProVerum Medical
|
ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. | $34.1M / Series A / Jan 11, 2022 | |
Tympany Medical
|
Tympany is a platform for performing minimally invasive ear surgeries, reducing unnecessary mastoidectomys and improving outcomes. | $3.9M / Seed / Nov 22, 2021 | |
LUMA Vision
|
OneProjects is an Irish-German cardiac imaging specialist. | $8M / Series A / Oct 14, 2021 | |
TerminusDB
|
TerminusDB is an open-source full-featured in-memory graph database management system with a rich query language, WOQL.TerminusDB allows for the whole suite of revision control features: branch, merge, squash, rollback, blame, and time-travel. It is about taking data seriously, structuring data to meet business needs, and reducing the coderequired to display, distribute and manipulate data and support great decision making.TerminusDB was previously known as DataChemist, was founded in Dublin, Ireland. | $4.3M / Seed / Mar 15, 2021 | |
Parvalis Therapeutics
|
Parvalis Therapeutics develops novel autoimmune therapies for inflammatory diseases and cancer. Founded in 2020, the company is based in Dublin, Ireland. | Seed / Jan 01, 2021 | |
| See all 33 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Atlantic Bridge University Fund invest in?
Atlantic Bridge University Fund invests primarily in Health Care, Medical Device and Big Data startups, most often at Seed and Series A stage. Most of the 33 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Atlantic Bridge University Fund's check size?
Atlantic Bridge University Fund typically joins rounds of $823k–$3.9M at Seed, $3.1M–$34M at Series A and $16M–$80M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Atlantic Bridge University Fund participates in.
How do I contact Atlantic Bridge University Fund?
Public channels for Atlantic Bridge University Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Atlantic Bridge University Fund?
The team at Atlantic Bridge University Fund includes Brian Long (Founder & Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
